Zobrazeno 1 - 10
of 24
pro vyhledávání: '"James M. Minor"'
BACKGROUND Diabetes health care relies on the HbA1c (A1c) assay and associated average glucose (AG) to evaluate and control chronic glycemia. However, the A1c assay is plagued with significant noise, lag time, and specificity issues. Current studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7146b4d4e6ba30282ba5dbadadefc201
https://europepmc.org/articles/PMC5950990/
https://europepmc.org/articles/PMC5950990/
Background: The chaotic nature of blood glucose creates a formidable clinical challenge for diabetes healthcare. The recent discovery of recurrent endocrine cycles offers the advantage of advanced-prediction (proactive) health care. Methods: Historic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41e8bbd98e667c822e5325d40f1e9641
https://europepmc.org/articles/PMC4928232/
https://europepmc.org/articles/PMC4928232/
Autor:
Suzanne Sysko Clough, Ann L. Gruber-Baldini, Maria C. Okafor, James M. Minor, Charlene C. Quinn, Dan Lender
Publikováno v:
Diabetes Technology & Therapeutics. 10:160-168
Less than 63% of individuals with diabetes meet professional guidelines target of hemoglobin A1c7.0%, and only 7% meet combined glycemic, lipid, and blood pressure goals. The primary study aim was to assess the impact on A1c of a cell phone-based dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b1e59f6fe0803d2f9d52d8da121271
https://doi.org/10.1089/dia.2008.0283
https://doi.org/10.1089/dia.2008.0283
Autor:
Leslie Rickey, James M. Minor
Publikováno v:
Journal of Urology. 185
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97ec99fd98e519014db5a09d0e9b8bf0
https://doi.org/10.1016/j.juro.2011.02.1945
https://doi.org/10.1016/j.juro.2011.02.1945
Autor:
James M, Minor
Publikováno v:
Methods in enzymology. 411
Physically separated groups of specific sequences (probes) provide useful high through put (HTP) measurements for the amount of selected DNA/RNA sequences in a biological target sample. Unfortunately, these measurements are impacted by various techni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::968c4ebf0f2380ded124ae8c305444dd
https://pubmed.ncbi.nlm.nih.gov/16939793
https://pubmed.ncbi.nlm.nih.gov/16939793
Autor:
James M. Minor
Physically separated groups of specific sequences (probes) provide useful high through put (HTP) measurements for the amount of selected DNA/RNA sequences in a biological target sample. Unfortunately, these measurements are impacted by various techni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::319d7a0ed625d6c74433e551772eabd2
https://doi.org/10.1016/s0076-6879(06)11012-5
https://doi.org/10.1016/s0076-6879(06)11012-5
Autor:
Mark R. Fielden, James M. Minor, Radha Idury, Simone M. Nicholson, Jian Yang, Leslie J. Browne, Alan H. Roter, Barrett P. Eynon, Kyle L. Kolaja, Naiomi C. Breckenridge, Ramesh V. Nair, Peter Nguyen, Siqi Tan, May D Lee, Brigitte Ganter, Gwo-Jen Day, Lindsay Brady, Shane Dunlea, Christopher McSorley, Susan Y. Fujimoto, Hang Pham, Dongxu Sun, Susanne Baumhueter, L. Mike Furness, Silke Thode, Alexander M. Tolley, Zhiming Zhou, Cecelia Pearson, Georges Natsoulis, Stuart Tugendreich, Christopher Hu, Kurt Jarnagin, Keith A. Bostian, John T. Calvin, Joe Ferng, Michael S.B. Judo, Li Gong, Eser Ayanoglu, Antoaneta Vladimirova
Publikováno v:
Journal of biotechnology. 119(3)
Successful drug discovery requires accurate decision making in order to advance the best candidates from initial lead identification to final approval. Chemogenomics, the use of genomic tools in pharmacology and toxicology, offers a promising enhance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65a92d42878471e7309a9e3586580030
https://pubmed.ncbi.nlm.nih.gov/16005536
https://pubmed.ncbi.nlm.nih.gov/16005536
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 14(2)
Quantification of hepatitis C virus (HCV) RNA in serum is used to assess the probability of treatment response and to monitor antiviral therapy. Since serum specimens often are shipped to central sites for HCV RNA testing, it is important to define c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db37618a72833435d6343e715762631e
https://pubmed.ncbi.nlm.nih.gov/10588456
https://pubmed.ncbi.nlm.nih.gov/10588456
Publikováno v:
Journal of clinical microbiology. 37(6)
Quantification of hepatitis B virus (HBV) DNA and hepatitis C virus (HCV) RNA often is performed in specimens that have been frozen and thawed more than once. To ensure optimal therapeutic and prognostic value, it is important to establish whether vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17b080291d5b3b6dff0238885b31687c
https://pubmed.ncbi.nlm.nih.gov/10325307
https://pubmed.ncbi.nlm.nih.gov/10325307
Autor:
Gordon F. Kapke, Lorraine Comanor, James M. Minor, Mel Krajden, Anna Grigoriew, Oretta Rifkin
Publikováno v:
Journal of clinical microbiology. 36(2)
Quantification of hepatitis B virus (HBV) DNA in serum is used to establish eligibility for treatment and to monitor therapeutic response. With the trend toward centralized testing, defining the conditions that preserve sample integrity is of paramou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c50966d29f446edded4131557c6b9c
https://pubmed.ncbi.nlm.nih.gov/9466745
https://pubmed.ncbi.nlm.nih.gov/9466745